BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32401925)

  • 21. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
    Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
    Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
    Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
    Li CL; Chang L; Guo L; Zhao D; Liu HB; Wang QS; Zhang P; Du WZ; Liu X; Zhang HT; Liu Y; Zhang Y; Xie JH; Ming JG; Cui YQ; Sun Y; Zhang ZR; Jiang CL
    Asian Pac J Cancer Prev; 2014; 15(23):10407-12. PubMed ID: 25556484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
    Zou B; Li QQ; Zhao J; Li JM; Cuff CF; Reed E
    Anticancer Res; 2013 Mar; 33(3):929-40. PubMed ID: 23482764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway.
    Liu X; Xu Y; Zhang L; Liu T; Zhang H
    Med Sci Monit; 2018 Jun; 24():4137-4145. PubMed ID: 29909423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
    Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
    Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression.
    Yan C; Yang J; Shen L; Chen X
    Arch Gynecol Obstet; 2012 Feb; 285(2):459-67. PubMed ID: 21698451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
    Liu YK; Jia YJ; Liu SH; Ma J
    Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
    Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
    Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
    Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
    Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
    Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
    Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astaxanthin Combine with Human Serum Albumin to Abrogate Cell Proliferation, Migration, and Drug-resistant in Human Ovarian Carcinoma SKOV3 Cells.
    Su XZ; Chen R; Wang CB; Ouyang XL; Jiang Y; Zhu MY
    Anticancer Agents Med Chem; 2019; 19(6):792-801. PubMed ID: 30799797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse.
    Azuma H; Tomita N; Sakamoto T; Kiyama S; Inamoto T; Takahara K; Kotake Y; Segawa N; Morishita R; Takahara S; Hayasaki H; Otsuki Y; Horie S; Tanigawa N; Katsuoka Y
    Int J Cancer; 2008 Apr; 122(7):1645-56. PubMed ID: 18058816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
    Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
    Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
    Long J; Liu Z; Hui L
    BMC Complement Altern Med; 2019 Jun; 19(1):133. PubMed ID: 31215421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.
    Lee RX; Li QQ; Reed E
    Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growth.
    Ahn JH; Yang YI; Lee KT; Choi JH
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):255-68. PubMed ID: 25216701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.